Adjuvanted Monovalent Influenza Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adjuvanted Monovalent Influenza Vaccine, covering 2013-01-18 to 2013-01-18. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects [Phase 3]